Prognostic value of hyperuricemia in patients with acute coronary syndrome: A meta-analysis

Cuifang He1, Peihuan Lin1, Wenbing Liu1

  • 1Department of CCU, The No.6 People's Hospital, Huizhou, China.

Insights

Elevated uric acid levels, or hyperuricemia, independently predict major adverse cardiovascular events and death in acute coronary syndrome (ACS) patients. This finding can improve risk stratification for ACS outcomes.

Area of Science:

  • Cardiology
  • Clinical Biochemistry

Background:

  • The prognostic value of elevated uric acid in acute coronary syndrome (ACS) patients remains debated.
  • Hyperuricemia is a common finding in patients with cardiovascular disease.

Purpose of the Study:

  • To evaluate the prognostic significance of hyperuricemia in patients diagnosed with acute coronary syndrome (ACS).
  • To assess the association between high uric acid levels and adverse cardiovascular outcomes in ACS patients.

Main Methods:

  • A systematic literature search was conducted across multiple databases (PubMed, Embase, VIP, CNKI, WanFang) up to June 2018.
  • Included observational studies investigating hyperuricemia and its association with major adverse cardiovascular events (MACEs), all-cause mortality, or cardiovascular mortality in ACS patients.

Main Results:

  • Nine studies involving 8776 ACS patients were analyzed.
  • Hyperuricemia was associated with a significantly increased risk of MACEs (RR: 1.86), all-cause mortality (RR: 1.86), and cardiovascular mortality (RR: 1.74) after adjusting for conventional risk factors.
  • Stratified analyses confirmed the consistent prognostic significance of hyperuricemia across subgroups.

Conclusions:

  • Hyperuricemia serves as an independent predictor of adverse outcomes, including MACEs and mortality, in ACS patients.
  • Measuring uric acid levels holds potential for enhancing the risk stratification of ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
958
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
324
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
267
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
286
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
420
Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K